This study provides evidence that RPV-induced activation of STAT1 in non-parenchymal cells attenuates liver injury in PLWH and MASLD, a result that is in line with our previous data suggesting a hepatoprotective role of RPV [3]. Here, STAT1 is linked to metabolic dysfunction-associated steatotic liver disease.